Trial Profile
Efficacy of Self-management of Sedative Therapy by Ventilated ICU Patients
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 17 Nov 2023
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Sedation
- Focus Therapeutic Use
- 08 Nov 2023 Planned number of patients changed from 228 to 190.
- 08 Nov 2023 Planned End Date changed from 1 Jul 2024 to 1 Dec 2024.
- 08 Nov 2023 Planned primary completion date changed from 1 Dec 2023 to 1 Apr 2024.